ziprasidone hydrochloride

Product NDC
50090-4821
11-digit product format
500904821
Labeler code
50090
Product ID
50090-4821_a16c9264-87ca-414d-a504-ba0a85334b77
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
ziprasidone hydrochloride
Dosage form
CAPSULE
Route
ORAL
Labeler
A-S Medication Solutions
Application
ANDA077565
Marketing category
ANDA
Marketing start
2018-07-26
Marketing end
0000-00-00
Substance
ZIPRASIDONE HYDROCHLORIDE
Active strength
20 mg/1
Pharmacologic classes
Atypical Antipsychotic [EPC]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
50090-4821-02023-02-07C16284748780-1f386c649-b237-0266-e053-dadaa90a7c1a488b931f-9bd6-4bc1-9823-79eccdfcf07f
50090-4821-02023-01-30C16284748780-1f386c649-b237-0266-e053-dadaa90a7c1a488b931f-9bd6-4bc1-9823-79eccdfcf07f

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
50090-4821-05009048210040 CAPSULE in 1 BOTTLE (50090-4821-0) 40 capsule2019-12-310000-00-00NoNoCurrent